Skip to main content

Table 4 Non-hematological toxicity in 40 patients

From: Phase II study of epirubicin, oxaliplatin and docetaxel combination in metastatic gastric or gastroesophageal junction adenocarcinoma

Toxicity

Grade 1%

Grade 2

%

Grade 3

%

Nausea/Vomiting

20

15

5

Mucositis

10

10

5

Diarrhea

10

10

2.5

Fatigue

20

20

5

Fluid retention*

20

5

-

Alopecia

15

50

35

Neurotoxicity

25

15

5

Hypersensitivity reaction

5

2.5

-

  1. • Grade 1–2: mild; grade 3: severe